P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC)

P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC)

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) Vol. 20; p. S66
Main Authors: Vassilaki, M, Sioulas, A, Tsantekidou, M, Klitsa, A, Desses, N, Georgakopoulos, C, Kosmidis, C, Tsionou, C, Parassiris, V, Xepapadakis, G
Format: Journal Article
Language:English
Published: Elsevier Ltd 2011
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0960-9776
1532-3080
DOI:10.1016/S0960-9776(11)70217-X